Insights

Insights

Filter by:
Governing Laws
Sector Life sciences & healthcare
Sub-sector
Service
Sub-service
Hot Topics
office-building-facades
Private equity

Advising The Rohatyn Group on investment in Optimapharm d.d.

22 May 2020
QUICK READ

by multiple authors

Click here to find out more
server-room
Coronavirus

What you need to know about the UK Government's new Future Fund 2.0

19 May 2020
IN-DEPTH ANALYSIS

by multiple authors

Click here to find out more
fibre-optic-cable
Coronavirus

Landmark Future Fund to open 20 May

19 May 2020
QUICK READ

by multiple authors

Click here to find out more
Environmental, planning & regulatory

Hope for compensation for Corona-related plant closures increases

15 May 2020

by Karolina Lange, LL.M. (Medizinrecht) and Juliane Dost

Click here to find out more
centrifuge-machine
Synapse

NHS can procure drugs for use outside of their approved indications if it's cheaper, court says

4 May 2020
IN-DEPTH ANALYSIS

by Justyna Ostrowska

Click here to find out more
Life sciences & healthcare

Renowned Life Sciences specialist Alison Dennis joins Taylor Wessing

1 May 2020

by multiple authors

Click here to find out more
patterned-pills
Synapse

Patents diary: April 2020

30 April 2020
QUICK READ

by Paul England, DPhil

Click here to find out more
colourful-tech
Coronavirus

What you need to know about the UK government's new Future Fund

27 April 2020
IN-DEPTH ANALYSIS

by multiple authors

Click here to find out more
blueprints
Synapse

Patent pools: an easy licensing option for COVID-19 drugs and SARS CoV 2 vaccines?

22 April 2020
IN-DEPTH ANALYSIS

by Dr. Anja Lunze, LL.M. and Dr. Jan Phillip Rektorschek

Click here to find out more
Technology, media & communications

Taylor Wessing advises UK Government on establishment of new £500m 'Future Fund' to support start-up technology and life sciences companies

21 April 2020

by Angus Miln

Click here to find out more
petri dishes
Patents & innovation

COVID-19 and public compulsory licensing of drugs in Europe

17 April 2020
IN-DEPTH ANALYSIS

by multiple authors

Click here to find out more
pipette
Synapse

COVID-19 and life sciences M&A

16 April 2020
IN-DEPTH ANALYSIS

by multiple authors

Click here to find out more